case
patient
woman
histori
idiopath
pulmonari
fibrosi
statu
post
bilater
lung
transplant
migrain
hypercoagul
multipl
sclerosi
ms
chronic
immunosuppress
admit
univers
california
lo
angel
medic
center
octob
day
fever
headach
nausea
vomit
neck
stiff
photophobia
patient
hospit
day
prior
admiss
outsid
hospit
complain
worst
headach
life
hospit
treat
varieti
abort
migrain
medic
partial
respons
diagnos
tacrolimu
toxic
initi
tacrolimu
level
ngml
ngml
discharg
acut
kidney
injuri
note
symptom
occur
set
year
msattribut
episod
leg
pain
swell
year
occasion
wordfind
difficulti
slur
speech
year
recurr
episod
dizzi
fall
month
lower
extrem
weak
addit
patient
acut
episod
encephalopathi
firsttim
seizur
unclear
etiolog
march
patient
resid
orang
counti
california
deni
sick
contact
pet
anim
exposur
insect
bite
eat
shellfish
game
meat
report
travel
mountain
utah
august
caribbean
throughout
europ
decad
admiss
outpati
medic
includ
immunosuppress
medic
tacrolimu
mycophenol
mofetil
prednison
lung
transplant
teriflunomid
ms
antimicrobi
prophylaxi
trimethoprimsulfamethoxazol
acyclovir
anticoagul
pain
medic
includ
intrathec
morphin
pump
upon
admiss
patient
note
sleepi
fulli
orient
moder
distress
pain
fever
otherwis
normal
vital
sign
physic
exam
remark
right
leg
tender
deep
venou
thrombosi
initi
exam
show
stabl
pancytopenia
white
blood
cell
platelet
count
respect
hemoglobin
gdl
elev
transaminas
alanin
aminotransferas
aspart
aminotransferas
ul
ul
respect
elev
intern
normal
ratio
tacrolimu
level
ngml
magnet
reson
imag
reveal
baselin
periventricular
subcort
juxtacort
white
matter
intens
associ
ms
acut
chang
tabl
empir
antimicrobi
initi
vancomycin
ceftazidim
acyclovir
voriconazol
tacrolimu
initi
held
subsequ
resum
given
patient
ongo
symptom
lumbar
punctur
perform
day
reveal
lymphocyt
pleocytosi
tabl
clinic
microbiolog
studi
return
neg
tabl
day
patient
clinic
improv
except
mild
persist
headach
differenti
diagnosi
includ
viral
meningoenceph
tacrolimu
toxic
patient
identifi
possibl
pdaid
case
base
unknown
etiolog
meningoenceph
cerebrospin
fluid
sampl
day
hospit
analyz
clinic
mng
test
univers
california
san
francisco
dna
rna
sequenc
librari
yield
read
respect
analysi
use
sequencebas
ultrarapid
pathogen
identif
surpi
clinic
bioinformat
pipelin
detect
hev
assembl
yield
complet
viral
genom
approxim
pairwis
ident
closest
match
refer
genbank
supplementari
figur
phylogenet
analysi
assign
genom
genotyp
close
relat
viral
strain
japan
southeast
asia
supplementari
figur
diagnosi
hevassoci
meningoenceph
commun
patient
review
patient
electron
medic
record
show
normal
transaminas
level
lung
transplant
persist
lowlevel
elev
transplant
supplementari
figur
patient
readmit
week
discharg
new
decompens
liver
diseas
encephalopathi
asterixi
ascit
cirrhosi
abdomin
ultrasound
liver
elastographi
hev
mng
result
prompt
immedi
followup
clinic
test
demonstr
serum
hev
immunoglobulin
igm
posit
neg
immunoglobulin
g
igg
plasma
hev
viremia
intern
unit
iu
ml
tabl
supplementari
figur
treatment
ribavirin
lowdos
diuret
hepat
e
viru
rna
declin
transaminas
normal
ascit
edema
mentat
improv
patient
subsequ
readmiss
headach
nausea
vomit
attribut
tacrolimu
toxic
side
effect
ribavirin
necessit
multipl
ribavirin
treatment
interrupt
case
report
unit
network
organ
share
donor
safeti
net
test
store
donor
serum
posit
hev
igg
igm
antibodi
neg
hev
rna
donor
report
woman
methamphetamin
use
central
california
without
clear
risk
factor
hev
infect
abnorm
transaminas
level
pretranspl
sampl
case
patient
avail
present
case
genotyp
hev
infect
lung
transplant
recipi
ms
immunosuppress
therapi
patient
symptom
lymphocyt
pleocytosi
admiss
consist
acut
viral
mening
tacrolimu
toxic
may
also
contribut
present
improv
rapidli
tacrolimu
discontinu
patient
persist
lowlevel
transamin
sever
year
admiss
subsequ
evid
cirrhosi
suggest
like
chronic
infect
hev
although
initi
test
hev
igg
neg
serolog
unreli
immunosuppress
patient
prior
episod
seizur
encephalopathi
also
suggest
chronic
neuroinvas
hev
diseas
intermitt
flare
although
develop
chronic
hev
infect
infrequ
gener
popul
solid
organ
transplant
sot
recipi
greater
risk
seri
sot
recipi
hev
infect
develop
chronic
hepat
patient
cirrhosi
develop
within
sever
year
neurolog
manifest
hev
infect
includ
inflammatori
polyradiculopathi
enceph
syndrom
seen
case
time
neurolog
manifest
hev
infect
well
describ
rang
month
review
case
immunosuppress
patient
anim
model
hev
abl
cross
barrier
replic
central
nervou
system
caus
neuron
necrosi
myelin
degener
hepat
e
viru
infect
infrequ
consid
infecti
caus
meningoenceph
specif
diagnost
test
routin
done
underscor
benefit
unbias
approach
mng
pathogen
detect
hepat
e
viru
infect
may
detect
serolog
test
concurr
blood
stool
hev
rna
test
recommend
especi
immunosuppress
patient
clinician
consid
hev
differenti
diagnosi
sot
immunosuppress
patient
unexplain
hepat
particularli
take
calcineurin
inhibitor
treatment
chronic
hev
infect
includ
reduct
immunosuppress
enabl
viral
clearanc
approxim
sot
patient
ribavirin
monotherapi
achiev
sustain
virolog
respons
approxim
patient
initi
patient
new
antivir
sofosbuvir
may
futur
role
treatment
notabl
patient
appear
contract
hev
donor
support
evid
includ
posit
antihev
iggigm
test
donor
serum
patient
persist
lowlevel
transaminas
elev
began
transplant
publish
report
donorderiv
hev
transmiss
liver
transplant
recipi
develop
cirrhosi
death
septic
shock
within
month
transplant
renal
transplant
recipi
donor
develop
cholestat
hepat
month
transplant
first
report
presumpt
hev
transmiss
lung
transplant
transplant
center
clinician
awar
potenti
hev
infect
donor
judg
elev
risk
